This inventor holds 2 USPTO granted patents. Top assignee: Panacea Pharmaceuticals, Inc.. Active years: 2004-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2009
Title: Natalie Ostretova-Golts: Innovator in Neurodegenerative Disease Research
Introduction
Natalie Ostretova-Golts is a prominent inventor based in Forrest Park, IL (US). She has made significant contributions to the field of neurodegenerative diseases, particularly through her innovative research and patented inventions. With a total of two patents to her name, her work focuses on addressing critical health challenges associated with alpha-synuclein diseases.
Latest Patents
Her latest patents include "Isolated peptides to treat alpha-synuclein diseases" and "Compositions for inhibiting the aggregation pathway of α-synuclein." The first patent relates to drug screening methods and strategies for preventing neural tissue damage caused by α-synuclein aggregation. This invention is particularly valuable in the design and development of inhibitors for Lewy body diseases and other synucleinopathies, with a focus on treating neurodegenerative diseases such as Parkinson's Disease. The second patent provides methods for determining the aggregation of α-synuclein, which is a hallmark of Lewy body diseases like Parkinson's disease. It also discloses inhibitors of this aggregation, including magnesium and α-synuclein binding peptides, which are useful in treating Lewy body diseases.
Career Highlights
Natalie is currently associated with Panacea Pharmaceuticals, Inc., where she continues her research and development efforts. Her work has positioned her as a key figure in the fight against neurodegenerative diseases, contributing to advancements that may lead to effective treatments.
Collaborations
Throughout her career, Natalie has collaborated with notable colleagues, including Benjamin Wolozin and Michael Lebowitz. These partnerships have enhanced her research capabilities and broadened the impact of her inventions.
Conclusion
Natalie Ostretova-Golts is a dedicated inventor whose work in neurodegenerative disease research is paving the way for innovative treatments. Her patents reflect her commitment to addressing critical health issues, particularly those related to alpha-synuclein diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile